anti-CD7 CAR-pNK cells: Clinical Trials

1 trial of anti-CD7 CAR-pNK cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow anti-CD7 CAR-pNK cells: new trials by email Literature Review of anti-CD7 CAR-pNK cells trials Research Report on anti-CD7 CAR-pNK cells

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma
anti-CD7 CAR-pNK cells - Acute Myeloid Leukemia, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Phase 1 / Phase 2UnknownPersonGen BioTherapeutics (Suzhou) Co., Ltd.102016-03-012016-12-06

Conditions studied

Enteropathy-Associated T-Cell Lymphoma (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Leukemia, Large Granular Lymphocytic (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Prolymphocytic, T-Cell (1)  ·  Lymphoma, Extranodal NK-T-Cell (1)  ·  Lymphoma, T-Cell (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)

Sponsors

PersonGen BioTherapeutics (Suzhou) Co., Ltd. (1)

Countries

China (1)

Top investigators

Lin Yang, Ph.D. (1)

Results publications

PMID 28054442